No effect of omega-3 carboxylic acid on MACE in high-risk patients
This video was recorded during the virtual congress of the AHA Scientific Sessions 2020.
Michael Lincoff is interventional cardiologist in the Heart, Vascular & Thoracic Institute, Cleveland Clinic, and Prof. of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University, Cleveland, OH, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: